She was treated with Mestinon and showed initial improvement, then in [**Month (only) 956**], last year she developed some slurred speech and her Mestinon dose was increased.
Her forced vital capacity was about 1.1 liters and she was initially admitted to the Intensive Care Unit.
The urinary tract infection was treated and she started a five day course of intravenous immunoglobulin.
She was also started on Prednisone 80 mg a day, and her Mestinon dose was increased.
She was started on Imuran initially although it was subsequently discontinued.
She was started on Cellcept at that point and started on plasmapheresis.
She continued to do quite well and ended up undergoing a thymectomy which she tolerated fairly well, however, postoperatively she had bilateral chest tubes with some mild pleural effusions and continued to complain of some shortness of breath.
Her shortness of breath gradually improved after the chest tubes were removed and she was discharged to home.
She was started on Ceftriaxone.
She was continued on steroids, Mestinon and Ceftriaxone.
Status post thymectomy several weeks ago.
MEDICATIONS ON ADMISSION:  Mestinon 60 mg p.o.
q. day; Prednisone 60 mg p.o.
q. day; Ceftriaxone 1 gm q. day.
However, her neck strength was somewhat reduced on flexion and extension.
HOSPITAL COURSE:  The patient is a 65 year old woman with a history of myasthenia [**Last Name (un) 2902**], ten days status post thymectomy presenting with worsening dysarthria and difficulty handling secretions as well as some shortness of breath.
She was continued on intravenous Mestinon, intravenous medications initially because she had difficulty swallowing.
She continued on Prednisone 80 mg p.o.
She continued on Mestinon 30 mg p.o.
Prednisone 80 mg p.o.
Mestinon 30 mg p.o.
